Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?

被引：9

作者：

Boers, M ^{[1
]}

机构：

[1] Vrije Univ Amsterdam, Ctr Med, Dept Clin Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands

来源：

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2004年 / 18卷 / 01期

关键词：

glucocorticoids; arthritis; rheumatoid; treatment; benefits and harms; review; scholarly;

D O I：

10.1016/j.berh.2003.10.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Treatment of rheumatoid arthritis with glucocorticoids remains controversial despite a considerable and growing body of evidence. This chapter focuses on the research agenda in urgent need of execution: to define conclusively the benefit/harm trade-offs and pin down the place of these agents in the treatment cascade.

引用

页码：21 / 29

页数：9

共 36 条

[21]

Lodder MC, 2003, ANN RHEUM DIS, V62, P94

[22] Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial [J].

Moreland, LW ;

Schiff, MH ;

Baumgartner, SW ;

Tindall, EA ;

Fleischmann, RM ;

Bulpitt, KJ ;

Weaver, AL ;

Keystone, EC ;

Furst, DE ;

Mease, PJ ;

Ruderman, EM ;

Horwitz, DA ;

Arkfeld, DG ;

Garrison, L ;

Burge, DJ ;

Blosch, CM ;

Lange, MLM ;

McDonnell, ND ;

Weinblatt, ME .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :478-+

[23] CORTICOSTEROID USE AND PEPTIC-ULCER DISEASE - ROLE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].

PIPER, JM ;

RAY, WA ;

DAUGHERTY, JR ;

GRIFFIN, MR .

ANNALS OF INTERNAL MEDICINE, 1991, 114 (09) :735-740

[24] The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: A re-examination of the evidence [J].

Rubin, MR ;

Bilezikian, JP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) :4033-4041

[25] LOW-DOSE LONG-TERM CORTICOSTEROID-THERAPY IN RHEUMATOID-ARTHRITIS - AN ANALYSIS OF SERIOUS ADVERSE EVENTS [J].

SAAG, KG ;

KOEHNKE, R ;

CALDWELL, JR ;

BRASINGTON, R ;

BURMEISTER, LF ;

ZIMMERMAN, B ;

KOHLER, JA ;

FURST, DE .

AMERICAN JOURNAL OF MEDICINE, 1994, 96 (02) :115-123

[26] OSTEOPOROSIS IN RHEUMATOID-ARTHRITIS - SAFETY OF LOW-DOSE CORTICOSTEROIDS [J].

SAMBROOK, PN ;

EISMAN, JA ;

YEATES, MG ;

POCOCK, NA ;

EBERL, S ;

CHAMPION, GD .

ANNALS OF THE RHEUMATIC DISEASES, 1986, 45 (11) :950-953

[27] Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial [J].

Smolen, JS ;

Kalden, JR ;

Scott, DL ;

Rozman, B ;

Kvien, TK ;

Larsen, A ;

Loew-Friedrich, I ;

Oed, C ;

Rosenburg, R .

LANCET, 1999, 353 (9149) :259-266

[28]

STUCK AE, 1989, REV INFECT DIS, V11, P954

[29] Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects - A randomized, double-blind, placebo-controlled clinical trial [J].

van Everdingen, AA ;

Jacobs, JWG ;

van Reesema, DRS ;

Bijlsma, JWJ .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (01) :1-12

[30]

Verhoeven AC, 1997, J RHEUMATOL, V24, P1495

← 1 2 3 4 →